Philip J. Dolan

2.3k total citations
14 papers, 1.1k citations indexed

About

Philip J. Dolan is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Philip J. Dolan has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Philip J. Dolan's work include Alzheimer's disease research and treatments (9 papers), Mitochondrial Function and Pathology (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Philip J. Dolan is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Mitochondrial Function and Pathology (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Philip J. Dolan collaborates with scholars based in United States. Philip J. Dolan's co-authors include Gail V.W. Johnson, Huiping Ding, Rodrigo A. Quintanilla, Youngnam N. Jin, Kaihong Mi, Gozde Colak, Anthony J. Filiano, Janusz Tucholski, Rakhi Kohli and Shirley Eberly and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Neurology.

In The Last Decade

Philip J. Dolan

13 papers receiving 1.0k citations

Peers

Countries citing papers authored by Philip J. Dolan

Since Specialization

Citations

This map shows the geographic impact of Philip J. Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Dolan more than expected).

Fields of papers citing papers by Philip J. Dolan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Dolan. The network helps show where Philip J. Dolan may publish in the future.

Co-authorship network of co-authors of Philip J. Dolan

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Dolan. A scholar is included among the top collaborators of Philip J. Dolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Dolan. Philip J. Dolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Binding Characteristics of PRX012 Surrogate Demonstrate Potent Engagement of Toxic Amyloid Beta Protofibrils and Robust Clearance of Pyroglutamate-modified Amyloid Beta (P7-9.003) 2024 ·Neurology ·Brian Campbell, Gang Zhang, (unknown), (unknown), Stephen J. Tam, Amir Porat, (unknown), Philip J. Dolan, Gene G. Kinney, Wagner Zago	0
2	PRX012 induces microglia‐mediated clearance of pyroglutamate‐modified Aβ in Alzheimer’s Disease brain tissue 2021 ·Alzheimer s & Dementia ·Stephen J. Tam, Gang Zhang, (unknown), (unknown), (unknown), Philip J. Dolan, Gene G. Kinney, Brian Campbell, Wagner Zago	4
3	2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis 2016 ·Amyloid ·Mark Renz, (unknown), Philip J. Dolan, Stephen J. Tam, (unknown), (unknown), (unknown), Robin Barbour, Paul J. Shughrue, Tarlochan Nijjar, Dale Schenk, Gene G. Kinney, Wagner Zago	33
4	NEOD001 Specifically Binds Aggregated Light Chain Infiltrates in Multiple Organs from Patients with AL Amyloidosis and Promotes Phagocytic Clearance of AL Aggregates in Vitro 2015 ·Blood ·Wagner Zago, Mark Renz, (unknown), Philip J. Dolan, Robin Barbour, (unknown), Paul J. Shughrue, Dale Schenk, Gene G. Kinney	1
5	The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics 2011 ·Journal of Cellular and Molecular Medicine ·(unknown), Philip J. Dolan, (unknown), Gail V.W. Johnson	64
6	Truncated tau and Aβ cooperatively impair mitochondria in primary neurons 2011 ·Neurobiology of Aging ·Rodrigo A. Quintanilla, Philip J. Dolan, Youngnam N. Jin, Gail V.W. Johnson	117
7	Decreases in valosin-containing protein result in increased levels of tau phosphorylated at Ser^262/356 2011 ·FEBS Letters ·Philip J. Dolan, Youngnam N. Jin, Woong Y. Hwang, Gail V.W. Johnson	8
8	Transglutaminase 2 protects against ischemic stroke 2010 ·Neurobiology of Disease ·Anthony J. Filiano, Janusz Tucholski, Philip J. Dolan, Gozde Colak, Gail V.W. Johnson	37
9	A Caspase Cleaved Form of Tau Is Preferentially Degraded through the Autophagy Pathway 2010 ·Journal of Biological Chemistry ·Philip J. Dolan, Gail V.W. Johnson	125
10	The role of tau kinases in Alzheimer's disease. 2010 ·PubMed ·Philip J. Dolan, Gail V.W. Johnson	134
11	Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons 2009 ·Journal of Biological Chemistry ·Rodrigo A. Quintanilla, (unknown), Philip J. Dolan, Gail V.W. Johnson	145
12	Histone deacetylase 6 interacts with the microtubule‐associated protein tau 2008 ·Journal of Neurochemistry ·Huiping Ding, Philip J. Dolan, Gail V.W. Johnson	297
13	The Low Density Lipoprotein Receptor-related Protein 6 Interacts with Glycogen Synthase Kinase 3 and Attenuates Activity 2005 ·Journal of Biological Chemistry ·Kaihong Mi, Philip J. Dolan, Gail V.W. Johnson	77
14	Use of Colchicine to Treat Severe Constipation in Developmentally Disabled Patients 1998 ·The Journal of the American Board of Family Medicine ·Paul Frame, Philip J. Dolan, Rakhi Kohli, Shirley Eberly	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact